Abstract:Tanshinone IIA (TS IIA) and Astragaloside IV (AS IV) are natural herbal products which exert anti-inflammatory and anti-oxidant effects in order to eliminate unstable plaque in atherosclerosis. However, the combined effect of these two drugs on atherosclerotic plaque vulnerability and its molecular mechanism remains unclear. In the current study, we evaluate the effects of TS IIA and AS IV on atherosclerotic unstable plaque stability, and then further explore the mechanism of TS IIA and AS IV intervention on unstable plaque in vivo and in vitro. Histological characterization of atherosclerotic plaques was measured by Hematoxylin-Eosin (HE), Masson's Trichrome and Oil Red O staining. Cellular lipid droplet was measured by Oil Red O staining. The size of atherosclerotic lesion areas and content of lipids and collagen in the right common carotid arteries of apoE-/- mice were examined by Hematoxylin-Eosin (HE), Oil-red O, and Masson staining, respectively. The protein expression levels of interleukin (IL)-6, tumor necrosis factor (TNF)-α and C-reactive protein (CRP) in ApoE-/- mice and RAW264.7 cells were determined by enzyme-linked immunosorbent assay. The protein expression levels of matrix metalloproteinase-9 (MMP-9) and endothelial nitric oxide synthase (eNOS) in ApoE-/- mice and RAW264.7 cells were determined by western blotting. In addition, the PI3K/AKT and TRL4/NF-κB signaling were determined by western blotting. Our results revealed that the combination of TS IIA and AS IV significantly decreased lipid areas, increased collagen content and thickened fibrous cap in the right common carotid arteries compared with ApoE (-/-) mice model group. TS IIA and AS IV visibly reduced the cytoplasmic lipid droplet accumulation induced by oxLDL in RAW 264.7 macrophages. The ApoE-/- mice model group and oxLDL -stimulated RAW 264.7 macrophages treated with TS IIA and AS IV showed a downregulation in IL-6, MMP-9, TNF-α and CRP protein expression and upregulation in eNOS protein expression. Furthermore, TSIIA and AS IV may activate PI3K/AKT signaling and suppress TLR4/NF-κB signaling in vivo and in vitro. Additionally, blocking the PI3K/Akt signaling enhanced the translocation of NF-κB to the nucleus, TLR4, IL-6, MMP-9, TNF-α and CRP expression and inhibited eNOS expression in TS IIA and AS IV-treated RAW 264.7 macrophages. Therefore, the present study implicates that TS IIA and AS IV reinforces plaque stability via PI3K/AKT and TLR4/NF-κB signaling. TS IIA and AS IV administration may provide the basis for a potential therapeutic approach for the inhibition of vulnerable atherosclerotic plaques.

Effect of Coptis Root Extract on Collagen Category and the Ratio of MMP-9 to TIMP-1 in Aortic Vulnerable Atherosclerotic Plaque of ApoE-gene Knockout Mice

Relationship Between Matrix Metalloproteinase-9 and Tissue Metalloproteinase Inhibitor-1 and Carotid Atheromatous Plaque Stability

Effect of Atorvastatin on MMP-9 and Tissue Factor Induced by Oxldl in Human Monocytes-Derived Macrophages

Effects of Herbs with the Effect of Activating Blood Circulation or Nourishing Qi or Elimating Phlegm on Inflammatory Reaction in Atherosclerotic Plaque in Aorta of ApoE-gene Knockout Mice

Effect of dragon's blood extract on atherosclerotic plaque stability and gene expression of scavenger receptor CD36 in aorta of ApoE-gene knockout mice

Effect of Water Extractives of Qixue Bingzhi Fang on Atherosclerotic Unstable Plaque Pathology and MMP-1 and TIMP-1 in Apolipoprotein E-Deficient Mice

The Effect of Panax Quinquefolius Saponin on the Gene Expressions of Perilipin and CD36 Assosciated with Lipid Metabolism of Apolipoprotein E-Gene Knockout Mice

Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling

The Effect of Guanxinshutong Capsule on the Expression of Matrix Metalloproteinases-9 and Tissue Matrix Metalloproteinase Inhibitor-1 of Atherosclerotic Plaque in ApoE-/-Mice

Emodin promotes atherosclerotic plaque stability in fat-fed apolipoprotein E-deficient mice.

Aggravated Restenosis and Atherogenesis in ApoCIII Transgenic Mice but Lack of Protection in ApoCIII Knockouts: the Effect of Authentic Triglyceride-Rich Lipoproteins with and Without ApoCIII.

Effects of Lercanidipine Hydrochloride on Elastic Lamina Degradation and Collagen Synthesis in Aortic Artery of the Apo E Gene Knock-out Hypertensive Mice with Atherosclerosis

Alprostadil Liposome Microsphere Preparation Stabilizes Vascular Plaques and Inhibits Intra-Plaque Inflammation.

Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially Via the TLR4/MyD88/NF-κB Signal Pathway

Aortic Artery Elastic Lamina Degradation, Collagen Remodeling, Oxides Stress and Inflammation in the Apolipoprotein E Deficient Mice with or Without Aortic Banding

Inhibitory Effect of Apolipoprotein A-I on Matrix Metalloproteinase-2 Expression in Vivo and in Vitro.

Ag1296 Enhances Plaque Stability Via Inhibiting Inflammatory Responses and Decreasing Mmp-2 and Mmp-9 Expression in Apoe-/- Mice

Effect of atorvastatin on matrix metalloproteinase 9 expression in the upstream shoulder of aortic atherosclerotic plaques in rabbits

S-propargyl-cysteine promotes the stability of atherosclerotic plaque via maintaining vascular muscle contractile phenotype

Atorvastatin Improves Plaque Stability In Apoe-Knockout Mice By Regulating Chemokines And Chemokine Receptors

The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice.